Trichomegaly secondary to erlotinib.
Desai
Rajen U
RU
Rachakonda
Leelanand P
LP
Saffra
Norman A
NA
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride; D005138:Eyebrows / Q000187:drug effects*; D005140:Eyelashes / Q000187:drug effects*; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors